Clinical Research Directory
Browse clinical research sites, groups, and studies.
Role of Glucagon-like Peptide-1 Receptor Agonists in Menstrual Irregularities in Adolescent Females With Type 1 Diabetes Mellitus
Sponsor: Ain Shams University
Summary
The aim of this study is to measure the frequency of menstrual irregularities among adolescent females with Type 1 diabetes mellitus and to assess the therapeutic effect of glucagon-like peptide-1 receptor agonist on menstrual irregularities in adolescent females with Type 1 diabetes mellitus .
Key Details
Gender
All
Age Range
12 Years - 18 Years
Study Type
INTERVENTIONAL
Enrollment
50
Start Date
2025-08-04
Completion Date
2026-08
Last Updated
2026-01-27
Healthy Volunteers
No
Conditions
Interventions
Dulaglutide
All studied patients with T1DM with poor glycemic control will be screened for menstrual irregularities based upon detailed history Taking, those who were found to have menstrual irregularities will be subdivided into 2 groups: * Group 1: will receive additional dulaglutide at a dose escalating from o.75 to 1.5 mg /week for 12 weeks to the conventional insulin therapy. * Group 2: will only receive conventional insulin therapy.
Locations (2)
Ain shams university
Cairo, Cairo Governorate, Egypt
Ain shams university
Cairo, Cairo Governorate, Egypt